See more : F.N.B. Corporation (FNB-PE) Income Statement Analysis – Financial Results
Complete financial analysis of Beijing Airdoc Technology Co., Ltd. (2251.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Beijing Airdoc Technology Co., Ltd., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- We-R-You Corp. (WERU) Income Statement Analysis – Financial Results
- NuVim, Inc. (NUVM) Income Statement Analysis – Financial Results
- Total Brain Limited (TTBLF) Income Statement Analysis – Financial Results
- Orange S.A. (ORA.PA) Income Statement Analysis – Financial Results
- Anhui Fuhuang Steel Structure Co., Ltd. (002743.SZ) Income Statement Analysis – Financial Results
Beijing Airdoc Technology Co., Ltd. (2251.HK)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.airdoc.com
About Beijing Airdoc Technology Co., Ltd.
Beijing Airdoc Technology Co., Ltd. provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions for medical institutions and consumer healthcare providers in Mainland China and internationally. It offers Airdoc-AIFUNDUS (1.0), an AI-based software as a medical device for auxiliary diagnosis of diabetic retinopathy; Airdoc-AIFUNDUS (2.0) for the auxiliary diagnosis of hypertensive retinopathy, retinal vein occlusion, and age-related macular degeneration; and Airdoc-AIFUNDUS (3.0) for the auxiliary diagnosis of pathological myopia, retinal detachment, glaucoma detection, cataracts detection, ICVD/ASCVD, gestational diabetic retinopathy, gestational hypertensive retinopathy, papilledema intracranial, hypertension retinopathy, and anemia. The company also provides health risk assessment solutions to detect risk indicators, such as various lesions and diseases, hyperthyroidism, graves ophthalmopathy, retinal vein occlusion, dementia, Parkinson's disease, atrial fibrillation, and arteriosclerosis in a range of healthcare environments, including health checkup centers, community clinics, insurance companies, optometry centers, and pharmacies. In addition, it offers hardware devices, including fundus cameras. The company was incorporated in 2015 and is headquartered in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 203.96M | 113.66M | 115.18M | 47.67M | 30.42M |
| Cost of Revenue | 78.83M | 57.81M | 44.94M | 18.59M | 14.31M |
| Gross Profit | 125.13M | 55.85M | 70.24M | 29.09M | 16.11M |
| Gross Profit Ratio | 61.35% | 49.14% | 60.98% | 61.01% | 52.96% |
| Research & Development | 111.64M | 125.59M | 64.27M | 42.31M | 41.21M |
| General & Administrative | 98.98M | 80.08M | 77.07M | 8.03M | 8.03M |
| Selling & Marketing | 100.65M | 100.00M | 72.59M | 25.80M | 13.13M |
| SG&A | 199.63M | 180.08M | 149.65M | 33.83M | 21.16M |
| Other Expenses | -186.14M | -7.05M | -2.90M | 9.60M | 5.79M |
| Operating Expenses | 125.13M | 298.63M | 211.02M | 85.75M | 68.16M |
| Cost & Expenses | 390.10M | 356.43M | 255.96M | 104.33M | 82.47M |
| Interest Income | 13.02M | 9.14M | 2.02M | 1.80M | 579.00K |
| Interest Expense | 545.00K | 439.00K | 298.00K | 22.00K | 46.00K |
| Depreciation & Amortization | 31.95M | 22.67M | 15.50M | 5.46M | 3.48M |
| EBITDA | -113.36M | -159.64M | -126.73M | -49.42M | -48.00M |
| EBITDA Ratio | -55.58% | -134.09% | -115.18% | -103.67% | -157.81% |
| Operating Income | -186.14M | -242.77M | -140.77M | -56.66M | -52.06M |
| Operating Income Ratio | -91.26% | -213.60% | -122.22% | -118.85% | -171.15% |
| Total Other Income/Expenses | 40.28M | -439.00K | -298.00K | -27.34M | -40.99M |
| Income Before Tax | -145.86M | -182.74M | -142.53M | -79.25M | -87.13M |
| Income Before Tax Ratio | -71.51% | -160.78% | -123.74% | -166.24% | -286.48% |
| Income Tax Expense | -205.00K | 4.49M | -5.53M | 375.00K | 7.00K |
| Net Income | -132.53M | -187.23M | -136.99M | -79.63M | -87.14M |
| Net Income Ratio | -64.98% | -164.74% | -118.94% | -167.03% | -286.50% |
| EPS | -1.28 | -1.82 | -1.69 | -0.79 | -0.84 |
| EPS Diluted | -1.28 | -1.82 | -1.69 | -0.77 | -0.84 |
| Weighted Avg Shares Out | 103.50M | 103.00M | 80.93M | 101.25M | 103.57M |
| Weighted Avg Shares Out (Dil) | 103.50M | 103.00M | 80.93M | 103.57M | 103.57M |
Source: https://incomestatements.info
Category: Stock Reports